DNA Script attracts $38.5 mln Series B
Paris-based DNA Script, a maker of synthetic nucleic acids, has raised $38.5 million in Series B financing. The investors included LSP, BPIFrance, Kurma Partners, Idinvest Partners, Illumina Ventures and M Ventures.
16 May 2019•1 min read
